-
Clinical Pharmacology: Advances and Applications
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Clinical outcomes of antimicrobial lock solutions used in a treatment modality: a retrospective case series analysis
Original Research
(2361) Views (944) Full article downloads
Authors: P Brandon Bookstaver, Katherine R Gerrald, Robert R Moran
Published Date June 2010
Volume 2010:2 Pages 123 - 130
DOI: http://dx.doi.org/10.2147/CPAA.S11262
P Brandon Bookstaver1, Katherine R Gerrald2, Robert R Moran3
1South Carolina College of Pharmacy, 3Health Science Research Core, University of South Carolina, Columbia, SC, USA; 2University of North Carolina Hospitals, Chapel Hill, NC, USA
Background: Antimicrobial lock therapy (ALT) may be considered as adjunctive therapy in the treatment of catheter-related bloodstream infections (CRBSI) when catheter removal is not a favorable option.
Objective: To evaluate the outcomes associated with ALT as adjunctive treatment of CRBSI.
Methods: This was a 24-month retrospective case series analysis evaluating patients treated for more than 24 hours with ALT. The primary outcome was blood culture sterilization for 30 days posttherapy. The impact of ALT duration and time to initiation on central venous catheter (CVC) salvage were evaluated. Logistic regression modeled the association between ALT and sterilization rates, with a prespecified level of significance (α) of 0.1.
Results: Twenty-six cases were included in data analysis. Patients included ranged from 5 months to 82 years of age; 77% of patients were receiving total parenteral nutrition or chemotherapy. The majority of patients received vancomycin, daptomycin, or gentamicin combined with heparin in a lock solution. Blood culture sterilization was achieved in 69.2% of cases, and sterilization plus CVC retention was achieved in 11 cases (42.3%). Longer durations of ALT (≥9 days) were significantly correlated with blood culture sterilization (odds ratio = 1.367, P = 0.077).
Conclusion: ALT used as an adjunct to systemic therapy for adequate duration in CRBSI can achieve CVC sterilization and retainment without subsequent infectious complications.
Keywords: antimicrobial lock therapy, central venous catheter, bacteremia, central lineassociated bloodstream infection
Other articles by Dr Brandon Bookstaver
Intravenous ibuprofen: the first injectable product for the treatment of pain and fever- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Tenofovir-associated bone density loss
- The benefits and risks of testosterone replacement therapy: a review
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




